IL-12-expressing mesenchymal stem cell vaccine GX-051
Term · Oncology and biomedicine · MLC-T-ONC-014348
Human mesenchymal stem cells (MSCs) transduced with a retroviral vector encoding a modified form of the cytokine interleukin-12 (IL-12), with potential immunomodulating and antineoplastic activities. Upon intratumoral administration, IL-12-expressing MSC vaccine GX-051 secretes IL-12. IL-12 activates the immune system by both promoting the secretion of interferon-gamma, which activates natural killer cells (NKs), and inducing cytotoxic T-cell responses, which may result in both decreased cell proliferation and increased cell death in tumor cells.
| Identifier | MLC-T-ONC-014348 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | MSCs/IL-12M |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014348",
"term": "IL-12-expressing mesenchymal stem cell vaccine GX-051",
"field": "Oncology and biomedicine",
"definition": "Human mesenchymal stem cells (MSCs) transduced with a retroviral vector encoding a modified form of the cytokine interleukin-12 (IL-12), with potential immunomodulating and antineoplastic activities. Upon intratumoral administration, IL-12-expressing MSC vaccine GX-051 secretes IL-12. IL-12 activates the immune system by both promoting the secretion of interferon-gamma, which activates natural killer cells (NKs), and inducing cytotoxic T-cell responses, which may result in both decreased cell proliferation and increased cell death in tumor cells.",
"abbreviation": "MSCs/IL-12M",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/il-12-expressing-mesenchymal-stem-cell-vaccine-gx-051/"
}
Record 8,992 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.